Kintara Therapeutics
Why Robinhood?
You can watch KTRA and buy or sell other stocks, ETFs, and their options commission-free!About KTRA
TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. The firm’s lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors.
KTRA Key Statistics
Stock Snapshot
Kintara Therapeutics(KTRA) stock is priced at $0.12, giving the company a market capitalization of 5.4M. It carries a P/E multiple of -0.34.
During the trading day, Kintara Therapeutics(KTRA) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Kintara Therapeutics(KTRA) stock has reached 0, versus its average volume of 98.35K.
Over the past 52 weeks, Kintara Therapeutics(KTRA) stock has traded between a high of $7.93 and a low of $1.80.
Over the past 52 weeks, Kintara Therapeutics(KTRA) stock has traded between a high of $7.93 and a low of $1.80.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.